[18F]Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Acute Staphylococcus aureus Vascular Graft Infection in a Rat Model - Scorecard - MDSpire
Advertisement
[18F]Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Acute Staphylococcus aureus Vascular Graft Infection in a Rat Model
Clinical Scorecard: Utilization of [18F]Fluorodeoxyglucose PET Imaging for Identifying and Tracking Acute Vascular Graft Infections Caused by Staphylococcus aureus in a Rat Model
At a Glance
Category
Detail
Condition
Vascular graft or endograft infections (VGEIs)
Key Mechanisms
Infection by Staphylococcus aureus or S. epidermidis leading to inflammation and metabolic activity detectable by FDG-PET
Target Population
Patients with vascular grafts at risk of infection; modeled in Sprague–Dawley rats
Care Setting
Vascular surgery and infectious disease management settings, including diagnostic imaging facilities
Key Highlights
FDG-PET can differentiate untreated S. aureus-infected grafts from uninfected grafts based on SUVmax uptake.
SUVmax declines over time despite persistent bacterial load, limiting FDG-PET's ability to monitor infection progression.
FDG-PET cannot distinguish between uninfected grafts and those with suppressed infection after antibiotic treatment due to reduced inflammation and infection encapsulation.
Guideline-Based Recommendations
Diagnosis
Use MAGIC criteria including suspicious metabolic activity on FDG-PET/CT for diagnosing VGEI.
Consider focal FDG uptake pattern and SUVmax as reliable PET/CT parameters for VGEI diagnosis.
Management
Gold standard treatment involves surgical removal of infected graft, graft replacement, and prolonged antibiotic therapy.
Antibiotic regimens such as daptomycin and rifampicin can suppress infection but may not eliminate bacterial load.
Monitoring & Follow-up
FDG-PET/CT may assist in deciding to continue or escalate antimicrobial therapy based on focal FDG uptake.
FDG-PET/CT is less reliable for deciding when to stop antibiotic therapy due to persistent FDG uptake despite clinical improvement.
Risks
High morbidity and mortality associated with VGEI (mortality up to 75%).
Potential false positives in FDG-PET due to uptake in noninfected grafts affecting diagnostic accuracy.
Patient & Prescribing Data
Rat model of vascular graft infection with Staphylococcus aureus
Antibiotic treatment with daptomycin and rifampicin reduced inflammation and FDG uptake but did not eradicate infection, indicating encapsulation and suppressed infection.
Clinical Best Practices
Employ FDG-PET/CT as part of a multimodal diagnostic approach for suspected VGEI.
Interpret FDG-PET findings cautiously, considering possible uptake in noninfected grafts and limitations in monitoring treatment response.
Combine imaging results with clinical, microbiological, and histological data for comprehensive infection assessment.
Use animal models to better understand infection progression and imaging characteristics to improve clinical protocols.
by Emma Faddy, Mikkel Illemann Johansen, Christoffer Gadeberg, Rikke Louise Meyer, Lars Østergaard, Cecilie Bay-Richter, Louise Kruse Jensen, Mikkel Holm Vendelbo, Nis Pedersen Jørgensen
